Charles Andrew Salzberg, MD Email Charles Andrew Salzberg
- PROFESSOR | Surgery, Plastic Surgery
- Plastic and Reconstructive Surgery
- Hospital Affiliations
- Mount Sinai St. Luke's and Mount Sinai West
- Mount Sinai Brooklyn
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Queens
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
New York, NY 10029
Cortlandt Manor, NY 10567
Goshen, NY 10924
Tarrytown, NY 10591
Dr. Salzberg is the Chief of the Division of Plastic and Reconstructive Surgery at The Mount Sinai Hospital and is a Professor of Surgery at the Icahn School of Medicine at Mount Sinai. He specializes in both cosmetic and breast surgery, including breast reconstruction.
Practicing since 1987, Dr. Salzberg is best known as the pioneer of Direct to Implant or “one-step” breast reconstruction which replaces the traditional Tissue Expander Method. Dr. Salzberg’s first Direct to Implant procedure was done in 2001; since then he has reconstructed more than 1,100 breasts on more than 650 patients as part of breast cancer treatment or prevention for women at high risk of breast cancer due to a BRCA mutation or family history. His experience with using Alloderm or Strattice tissue matrix as implant support allows him to overcome some of the most challenging cases such as bottoming out, rippling or wrinkling and fold malposition. Dr. Salzberg is also internationally recognized in Fat Transfer for Revision Breast Reconstruction along with NaturalFill Breast Augmentation.
He graduated from the University of Florida School of Medicine, where he earned a Medical Doctorate in 1981. Dr. Salzberg completed a residency in General Surgery at Mount Sinai Beth Israel (then known as Beth Israel Medical Center, 1981-87) and a Plastic Surgery residency at The Mount Sinai Hospital (1984-87).
American Board of Plastic Surgery
- Breast Augmentation
- Breast Reconstruction
MD, University of Florida
Internship, General Surgery
Beth Israel Medical Center
Residency, Plastic Surgery
Mount Sinai Hospital
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Salzberg did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.